Evidera
Paul Lozowicki is a research professional currently serving as Research Associate II at Evidera since July 2021, while also acting as an Independent Consultant for MembersFirst since October 2019, focusing on health economic research and consumer advocacy. Previously, Paul held the position of Client Services Manager at MembersFirst from August 2016 to August 2018, where significant improvements in client relations and operational efficiencies were implemented. Earlier experience includes a marketing and outreach internship at Loyola University Maryland, alongside research work transcribing and translating a medieval Latin manuscript. Paul earned a Master of Science in International Health Management from Imperial College Business School and a Bachelor of Arts in Economics and Philosophy from Loyola University Maryland.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.